179 related articles for article (PubMed ID: 27297481)
21. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China.
Xia Q; Zhao LL; Li F; Fan YM; Chen YY; Wu BB; Liu ZW; Pan AZ; Zhu M
Antimicrob Agents Chemother; 2015 Mar; 59(3):1690-5. PubMed ID: 25583712
[TBL] [Abstract][Full Text] [Related]
22. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B
Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359
[TBL] [Abstract][Full Text] [Related]
23. Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand.
Suthum K; Samosornsuk W; Samosornsuk S
J Infect Dev Ctries; 2020 Mar; 14(3):268-276. PubMed ID: 32235087
[TBL] [Abstract][Full Text] [Related]
24. Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.
Kim HJ; Kwak HK; Lee J; Yun YJ; Lee JS; Lee MS; Min SY; Park SK; Kang HS; Maeng YH; Kim SY; Kim SY; Kook YH; Kim YR; Lee KH
Int J Tuberc Lung Dis; 2012 Jan; 16(1):98-103. PubMed ID: 22236853
[TBL] [Abstract][Full Text] [Related]
25. Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
Werngren J; Sturegård E; Juréen P; Ängeby K; Hoffner S; Schön T
Antimicrob Agents Chemother; 2012 Mar; 56(3):1253-7. PubMed ID: 22203587
[TBL] [Abstract][Full Text] [Related]
26. Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
Huang HT; Lin WH; Chan TH; Jou R
J Microbiol Immunol Infect; 2023 Dec; 56(6):1236-1244. PubMed ID: 37690869
[TBL] [Abstract][Full Text] [Related]
27. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
28. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping].
Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G
Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.
Chiu YC; Huang SF; Yu KW; Lee YC; Feng JY; Su WJ
BMC Infect Dis; 2011 Sep; 11():240. PubMed ID: 21910892
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
31. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
[TBL] [Abstract][Full Text] [Related]
32. Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residents.
Pandey S; Lavu E; Congdon J; Moke R; Bainomugisa A; Coulter C
Tuberculosis (Edinb); 2018 Jul; 111():109-113. PubMed ID: 30029894
[TBL] [Abstract][Full Text] [Related]
33. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
Velásquez GE; Calderon RI; Mitnick CD; Becerra MC; Huang CC; Zhang Z; Contreras CC; Yataco RM; Galea JT; Lecca LW; Murray MB
Antimicrob Agents Chemother; 2016 Nov; 60(11):6766-6773. PubMed ID: 27600032
[TBL] [Abstract][Full Text] [Related]
34. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
Doustdar F; Khosravi AD; Farnia P
Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
[TBL] [Abstract][Full Text] [Related]
35. Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
Pierre-Audigier C; Surcouf C; Cadet-Daniel V; Namouchi A; Heng S; Murray A; Guillard B; Gicquel B
Int J Tuberc Lung Dis; 2012 Feb; 16(2):221-3, i-ii. PubMed ID: 22236923
[TBL] [Abstract][Full Text] [Related]
36. Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study.
Sun F; Li Y; Chen Y; Guan W; Jiang X; Wang X; Ren P; Li J; Shi J; He G; Wu M; Tang P; Wang F; Sheng Y; Huang F; Zhou Z; Huang H; Hong L; Liu Q; Zhang Y; Zhang W
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30578402
[TBL] [Abstract][Full Text] [Related]
37. pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.
Zheng X; Ning Z; Drobniewski F; Yang J; Li Q; Zhang Z; Hu Y
Int J Antimicrob Agents; 2017 Feb; 49(2):183-188. PubMed ID: 28012685
[TBL] [Abstract][Full Text] [Related]
38. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.
Mphahlele M; Syre H; Valvatne H; Stavrum R; Mannsåker T; Muthivhi T; Weyer K; Fourie PB; Grewal HM
J Clin Microbiol; 2008 Oct; 46(10):3459-64. PubMed ID: 18753350
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis.
Whitfield MG; Streicher EM; Dolby T; Simpson JA; Sampson SL; Van Helden PD; Van Rie A; Warren RM
Tuberculosis (Edinb); 2016 Jul; 99():128-130. PubMed ID: 27450014
[TBL] [Abstract][Full Text] [Related]
40. Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.
Pholwat S; Stroup S; Gratz J; Trangan V; Foongladda S; Kumburu H; Juma SP; Kibiki G; Houpt E
Tuberculosis (Edinb); 2014 Jan; 94(1):20-5. PubMed ID: 24246607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]